A prospective longitudinal study of Pasireotide in Nelson's syndrome.

2.50
Hdl Handle:
http://hdl.handle.net/10541/620821
Title:
A prospective longitudinal study of Pasireotide in Nelson's syndrome.
Authors:
Daniel, E; Debono, M; Caunt, S; Girio-Fragkoulakis, C; Walters, S; Akker, S; Grossman, A; Trainer, Peter J; Newell-Price, J
Abstract:
Nelson's syndrome is a challenging condition that can develop following bilateral adrenalectomy for Cushing's disease, with high circulating ACTH levels, pigmentation and an invasive pituitary tumor. There is no established medical therapy. The aim of the study was to assess the effects of pasireotide on plasma ACTH and tumor volume in Nelson's syndrome.
Affiliation:
Department of Oncology and Metabolism, The Medical School, University of Sheffield, Beech Hill Road, Sheffield, S10 2RX, UK
Citation:
A prospective longitudinal study of Pasireotide in Nelson's syndrome. 2018 Pituitary
Journal:
Pituitary
Issue Date:
8-Jan-2018
URI:
http://hdl.handle.net/10541/620821
DOI:
10.1007/s11102-017-0853-3
PubMed ID:
29313180
Type:
Article
Language:
en
ISSN:
1573-7403
Appears in Collections:
All Christie Publications

Full metadata record

DC FieldValue Language
dc.contributor.authorDaniel, Een
dc.contributor.authorDebono, Men
dc.contributor.authorCaunt, Sen
dc.contributor.authorGirio-Fragkoulakis, Cen
dc.contributor.authorWalters, Sen
dc.contributor.authorAkker, Sen
dc.contributor.authorGrossman, Aen
dc.contributor.authorTrainer, Peter Jen
dc.contributor.authorNewell-Price, Jen
dc.date.accessioned2018-02-12T14:12:43Z-
dc.date.available2018-02-12T14:12:43Z-
dc.date.issued2018-01-08-
dc.identifier.citationA prospective longitudinal study of Pasireotide in Nelson's syndrome. 2018 Pituitaryen
dc.identifier.issn1573-7403-
dc.identifier.pmid29313180-
dc.identifier.doi10.1007/s11102-017-0853-3-
dc.identifier.urihttp://hdl.handle.net/10541/620821-
dc.description.abstractNelson's syndrome is a challenging condition that can develop following bilateral adrenalectomy for Cushing's disease, with high circulating ACTH levels, pigmentation and an invasive pituitary tumor. There is no established medical therapy. The aim of the study was to assess the effects of pasireotide on plasma ACTH and tumor volume in Nelson's syndrome.en
dc.language.isoenen
dc.rightsArchived with thanks to Pituitaryen
dc.titleA prospective longitudinal study of Pasireotide in Nelson's syndrome.en
dc.typeArticleen
dc.contributor.departmentDepartment of Oncology and Metabolism, The Medical School, University of Sheffield, Beech Hill Road, Sheffield, S10 2RX, UKen
dc.identifier.journalPituitaryen

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.